Cambridge Consultants To Showcase Inhaler Design And Development Process At RDD 2009, Europe

Main Category: Respiratory / Asthma
Article Date: 18 May 2009 - 3:00 PDT

email icon email to a friend   printer icon printer friendly   write icon opinions  

Current Article Ratings:

Patient / Public:not yet rated

Healthcare Prof:not yet rated


Cambridge Consultants will be showcasing its proprietary design and development process for Dry Power Inhalers (DPIs) at the Respiratory Drug Delivery (RDD) Europe 2009 conference in Lisbon later this month.  The company will demonstrate its ability to move inhaler design quickly through all stages of development from concept through manufacture to final product, getting it right first time, accelerating the creation of new inhalable drug delivery devices, and offering pharmaceutical companies a quick route to market, saving up to six months in development.

"Our RDD presence is all about the importance of speed to market, and this demonstration is designed to highlight the range of development capabilities we can deploy to achieve it for our clients," commented David Blakey, Head of Drug Delivery at Cambridge Consultants.  "It is crucial to ensure process quality in stages such as concept creation, complex mathematical modelling and detailed design.  These are areas where Cambridge Consultants adds significant value, based on our skill and experience in running turn key developments, from concept to clinical trial and through transfer to manufacture."

Cambridge Consultants will be using Gen-X, a proprietary DPI, to demonstrate the key stages in the design cycle.  The display tracks the stages of the process up to the test bed stage, where the efficacy of the de-aggregation engine has been tested.  Cambridge Consultants is currently selecting development partners to take this concept to market.

David Blakey adds: "Supported by our proprietary design and development process, our partners can cut up to six months off the development cycle for DPIs, giving them a significant head start and reducing development risk."

The demonstration of Cambridge Consultants' product development process will be available on Cambridge Consultants' stand at the Respiratory Drug Delivery Europe 2009 conference in Lisbon, Portugal, from 19-22 May.

Source
Cambridge Consultants

Article adapted by Medical News Today from original press release.
Visit our respiratory / asthma section for the latest news on this subject.
There are no references listed for this article.
Please use one of the following formats to cite this article in your essay, paper or report:

MLA
Cambridge Consultants. "Cambridge Consultants To Showcase Inhaler Design And Development Process At RDD 2009, Europe." Medical News Today. MediLexicon, Intl., 18 May. 2009. Web.
15 Feb. 2012. <http://www.medicalnewstoday.com/releases/150412.php>

APA
Cambridge Consultants. (2009, May 18). "Cambridge Consultants To Showcase Inhaler Design And Development Process At RDD 2009, Europe." Medical News Today. Retrieved from
http://www.medicalnewstoday.com/releases/150412.php.

Please note: If no author information is provided, the source is cited instead.


Respiratory / Asthma

What is Asthma?

Asthma is a disease affecting the airways that carry air to and from your lungs. People who suffer from this chronic condition (long-lasting or recurrent) are said to be asthmatic. Read more...

Most Popular Articles



Follow Our Respiratory News On Twitter

Follow Us On Twitter
Get the latest news for this category delivered straight to your Twitter account. Simply visit our Respiratory / Asthma Twitter account and select the 'follow' option.



View list of all 'What Is...' articles »